- Home
- HCWC vs EVOK Comparison
HCWC vs EVOK Comparison
Compare HCWC & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWC
- EVOK
- Stock Information
- Founded
- HCWC N/A
- EVOK 2007
- Country
- HCWC
- EVOK United States
- Employees
- HCWC 450
- EVOK N/A
- Industry
- HCWC
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- HCWC
- EVOK Health Care
- Exchange
- HCWC NYSE
- EVOK Nasdaq
- Market Cap
- HCWC 5.0M
- EVOK 4.2M
- IPO Year
- HCWC N/A
- EVOK 2013
- Fundamental
- Price
- HCWC $0.42
- EVOK $2.95
- Analyst Decision
- HCWC
- EVOK
- Analyst Count
- HCWC 0
- EVOK 0
- Target Price
- HCWC N/A
- EVOK N/A
- AVG Volume (30 Days)
- HCWC N/A
- EVOK 14.3K
- Earning Date
- HCWC N/A
- EVOK 05-13-2025
- Dividend Yield
- HCWC N/A
- EVOK N/A
- EPS Growth
- HCWC N/A
- EVOK N/A
- EPS
- HCWC N/A
- EVOK N/A
- Revenue
- HCWC N/A
- EVOK $11,594,083.00
- Revenue This Year
- HCWC N/A
- EVOK $57.82
- Revenue Next Year
- HCWC N/A
- EVOK $59.12
- P/E Ratio
- HCWC N/A
- EVOK N/A
- Revenue Growth
- HCWC N/A
- EVOK 89.89
- 52 Week Low
- HCWC N/A
- EVOK $1.94
- 52 Week High
- HCWC N/A
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- HCWC N/A
- EVOK 38.86
- Support Level
- HCWC N/A
- EVOK $3.33
- Resistance Level
- HCWC N/A
- EVOK $3.66
- Average True Range (ATR)
- HCWC 0.00
- EVOK 0.29
- MACD
- HCWC 0.00
- EVOK -0.06
- Stochastic Oscillator
- HCWC 0.00
- EVOK 2.99
About HCWC HEALTHY CHOICE WELLNESS CORP
Healthy Choice Wellness Corp is a company engaged in providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The company has one reportable segment which is natural and organic retail stores.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.